Advertisement

Index by author

March 01, 1993; Volume 43,Issue 3

A

  1. Adham, N

    1. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
      N Adham, B Ellerbrock, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology March 1993, 43 (3) 427-433;

  2. Akiyoshi, J

    1. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.
      J Akiyoshi, C Hough and D M Chuang
      Molecular Pharmacology March 1993, 43 (3) 349-355;

  3. Amlaiky, N

    1. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
      H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen
      Molecular Pharmacology March 1993, 43 (3) 313-319;

  4. Andres, H

    1. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
      U Quast, K M Bray, H Andres, P W Manley, Y Baumlin and J Dosogne
      Molecular Pharmacology March 1993, 43 (3) 474-481;

  5. Arriza, J L

    1. Characterization of alpha 2-adrenergic receptor subtype-specific antibodies.
      H Kurose, J L Arriza and R J Lefkowitz
      Molecular Pharmacology March 1993, 43 (3) 444-450;

  6. Audia, J E

    1. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
      D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
      Molecular Pharmacology March 1993, 43 (3) 419-426;

  7. Austin, E A

    1. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.
      E A Austin and B E Huber
      Molecular Pharmacology March 1993, 43 (3) 380-387;

B

  1. Baez, M

    1. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
      D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
      Molecular Pharmacology March 1993, 43 (3) 419-426;

  2. Barber, R

    1. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
      D Stickle and R Barber
      Molecular Pharmacology March 1993, 43 (3) 397-411;

  3. Baudry, M

    1. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states.
      R A Hall, G Massicotte, M Kessler, M Baudry and G Lynch
      Molecular Pharmacology March 1993, 43 (3) 459-464;

  4. Baumlin, Y

    1. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
      U Quast, K M Bray, H Andres, P W Manley, Y Baumlin and J Dosogne
      Molecular Pharmacology March 1993, 43 (3) 474-481;

  5. Birnbaumer, L

    1. Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor.
      T Gudermann, F O Levy, M Birnbaumer, L Birnbaumer and A J Kaumann
      Molecular Pharmacology March 1993, 43 (3) 412-418;

  6. Birnbaumer, M

    1. Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor.
      T Gudermann, F O Levy, M Birnbaumer, L Birnbaumer and A J Kaumann
      Molecular Pharmacology March 1993, 43 (3) 412-418;

  7. Bolaños, J P

    1. Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain.
      J P Bolaños and J M Medina
      Molecular Pharmacology March 1993, 43 (3) 487-490;

  8. Boschert, U

    1. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
      H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen
      Molecular Pharmacology March 1993, 43 (3) 313-319;

  9. Branchek, T

    1. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
      N Adham, B Ellerbrock, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology March 1993, 43 (3) 427-433;

  10. Bray, K M

    1. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
      U Quast, K M Bray, H Andres, P W Manley, Y Baumlin and J Dosogne
      Molecular Pharmacology March 1993, 43 (3) 474-481;

  11. Brooker, G

    1. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
      M A Debernardi, R Munshi and G Brooker
      Molecular Pharmacology March 1993, 43 (3) 451-458;

C

  1. Carter, B D

    1. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
      B D Carter and F Medzihradsky
      Molecular Pharmacology March 1993, 43 (3) 465-473;

  2. Cho-Chung, Y S

    1. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
      C Rohlff, B Safa, A Rahman, Y S Cho-Chung, R W Klecker and R I Glazer
      Molecular Pharmacology March 1993, 43 (3) 372-379;

  3. Chuang, D M

    1. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.
      J Akiyoshi, C Hough and D M Chuang
      Molecular Pharmacology March 1993, 43 (3) 349-355;

  4. Clement, B

    1. N-hydroxylation of benzamidine to benzamidoxime by a reconstituted cytochrome P-450 oxidase system from rabbit liver: involvement of cytochrome P-450 IIC3.
      B Clement, F Jung and H Pfunder
      Molecular Pharmacology March 1993, 43 (3) 335-342;

  5. Cohen, M L

    1. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
      D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
      Molecular Pharmacology March 1993, 43 (3) 419-426;

D

  1. Debernardi, M A

    1. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
      M A Debernardi, R Munshi and G Brooker
      Molecular Pharmacology March 1993, 43 (3) 451-458;

  2. Dosogne, J

    1. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
      U Quast, K M Bray, H Andres, P W Manley, Y Baumlin and J Dosogne
      Molecular Pharmacology March 1993, 43 (3) 474-481;

  3. Duescher, R J

    1. Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes.
      P J Sausen, R J Duescher and A A Elfarra
      Molecular Pharmacology March 1993, 43 (3) 388-396;

E

  1. Elfarra, A A

    1. Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes.
      P J Sausen, R J Duescher and A A Elfarra
      Molecular Pharmacology March 1993, 43 (3) 388-396;

  2. Ellerbrock, B

    1. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
      N Adham, B Ellerbrock, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology March 1993, 43 (3) 427-433;

G

  1. Glazer, R I

    1. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
      C Rohlff, B Safa, A Rahman, Y S Cho-Chung, R W Klecker and R I Glazer
      Molecular Pharmacology March 1993, 43 (3) 372-379;

  2. Graeser, D

    1. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
      D Graeser and R R Neubig
      Molecular Pharmacology March 1993, 43 (3) 434-443;

  3. Grailhe, R

    1. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
      H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen
      Molecular Pharmacology March 1993, 43 (3) 313-319;

  4. Gudermann, T

    1. Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor.
      T Gudermann, F O Levy, M Birnbaumer, L Birnbaumer and A J Kaumann
      Molecular Pharmacology March 1993, 43 (3) 412-418;

  5. Guzelian, P S

    1. Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel.
      T A Kocarek, E G Schuetz and P S Guzelian
      Molecular Pharmacology March 1993, 43 (3) 328-334;

H

  1. Hall, R A

    1. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states.
      R A Hall, G Massicotte, M Kessler, M Baudry and G Lynch
      Molecular Pharmacology March 1993, 43 (3) 459-464;

  2. Hamblin, M W

    1. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
      F J Monsma, Y Shen, R P Ward, M W Hamblin and D R Sibley
      Molecular Pharmacology March 1993, 43 (3) 320-327;

  3. Harrison, N L

    1. Modulation of gating of cloned rat and human K+ channels by micromolar Zn2+.
      N L Harrison, H K Radke, M M Tamkun and D M Lovinger
      Molecular Pharmacology March 1993, 43 (3) 482-486;

  4. Hartig, P

    1. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
      N Adham, B Ellerbrock, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology March 1993, 43 (3) 427-433;

  5. Hen, R

    1. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
      H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen
      Molecular Pharmacology March 1993, 43 (3) 313-319;

  6. Hough, C

    1. Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.
      J Akiyoshi, C Hough and D M Chuang
      Molecular Pharmacology March 1993, 43 (3) 349-355;

  7. Huber, B E

    1. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.
      E A Austin and B E Huber
      Molecular Pharmacology March 1993, 43 (3) 380-387;

J

  1. Jung, F

    1. N-hydroxylation of benzamidine to benzamidoxime by a reconstituted cytochrome P-450 oxidase system from rabbit liver: involvement of cytochrome P-450 IIC3.
      B Clement, F Jung and H Pfunder
      Molecular Pharmacology March 1993, 43 (3) 335-342;

K

  1. Kaneda, T

    1. Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
      T Kaneda, Y Kitamura and Y Nomura
      Molecular Pharmacology March 1993, 43 (3) 356-364;

  2. Kaumann, A J

    1. Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor.
      T Gudermann, F O Levy, M Birnbaumer, L Birnbaumer and A J Kaumann
      Molecular Pharmacology March 1993, 43 (3) 412-418;

  3. Kessler, M

    1. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states.
      R A Hall, G Massicotte, M Kessler, M Baudry and G Lynch
      Molecular Pharmacology March 1993, 43 (3) 459-464;

  4. Kitamura, Y

    1. Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
      T Kaneda, Y Kitamura and Y Nomura
      Molecular Pharmacology March 1993, 43 (3) 356-364;

  5. Klecker, R W

    1. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
      C Rohlff, B Safa, A Rahman, Y S Cho-Chung, R W Klecker and R I Glazer
      Molecular Pharmacology March 1993, 43 (3) 372-379;

  6. Kocarek, T A

    1. Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel.
      T A Kocarek, E G Schuetz and P S Guzelian
      Molecular Pharmacology March 1993, 43 (3) 328-334;

  7. Kurose, H

    1. Characterization of alpha 2-adrenergic receptor subtype-specific antibodies.
      H Kurose, J L Arriza and R J Lefkowitz
      Molecular Pharmacology March 1993, 43 (3) 444-450;

  8. Kursar, J D

    1. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
      D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
      Molecular Pharmacology March 1993, 43 (3) 419-426;

L

  1. Lefkowitz, R J

    1. Characterization of alpha 2-adrenergic receptor subtype-specific antibodies.
      H Kurose, J L Arriza and R J Lefkowitz
      Molecular Pharmacology March 1993, 43 (3) 444-450;

  2. Levy, F O

    1. Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor.
      T Gudermann, F O Levy, M Birnbaumer, L Birnbaumer and A J Kaumann
      Molecular Pharmacology March 1993, 43 (3) 412-418;

  3. Liggett, S B

    1. Lack of beta 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human.
      R F Thomas and S B Liggett
      Molecular Pharmacology March 1993, 43 (3) 343-348;

  4. Lovinger, D M

    1. Modulation of gating of cloned rat and human K+ channels by micromolar Zn2+.
      N L Harrison, H K Radke, M M Tamkun and D M Lovinger
      Molecular Pharmacology March 1993, 43 (3) 482-486;

  5. Lucaites, V L

    1. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
      D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
      Molecular Pharmacology March 1993, 43 (3) 419-426;

  6. Lynch, G

    1. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states.
      R A Hall, G Massicotte, M Kessler, M Baudry and G Lynch
      Molecular Pharmacology March 1993, 43 (3) 459-464;

M

  1. Manley, P W

    1. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
      U Quast, K M Bray, H Andres, P W Manley, Y Baumlin and J Dosogne
      Molecular Pharmacology March 1993, 43 (3) 474-481;

  2. Massicotte, G

    1. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states.
      R A Hall, G Massicotte, M Kessler, M Baudry and G Lynch
      Molecular Pharmacology March 1993, 43 (3) 459-464;

  3. Mattei, M G

    1. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
      H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen
      Molecular Pharmacology March 1993, 43 (3) 313-319;

  4. Matthes, H

    1. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
      H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen
      Molecular Pharmacology March 1993, 43 (3) 313-319;

  5. Medina, J M

    1. Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain.
      J P Bolaños and J M Medina
      Molecular Pharmacology March 1993, 43 (3) 487-490;

  6. Medzihradsky, F

    1. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
      B D Carter and F Medzihradsky
      Molecular Pharmacology March 1993, 43 (3) 465-473;

  7. Mio, M

    1. Histamine-induced production of interleukin-1 alpha from murine bone marrow stromal cells and its inhibition by H2 blockers.
      K Tasaka, M Mio, M Shimazawa and N Nakaya
      Molecular Pharmacology March 1993, 43 (3) 365-371;

  8. Monsma, F J

    1. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
      F J Monsma, Y Shen, R P Ward, M W Hamblin and D R Sibley
      Molecular Pharmacology March 1993, 43 (3) 320-327;

  9. Munshi, R

    1. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
      M A Debernardi, R Munshi and G Brooker
      Molecular Pharmacology March 1993, 43 (3) 451-458;

  10. Muscatelli, F

    1. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
      H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen
      Molecular Pharmacology March 1993, 43 (3) 313-319;

N

  1. Nakaya, N

    1. Histamine-induced production of interleukin-1 alpha from murine bone marrow stromal cells and its inhibition by H2 blockers.
      K Tasaka, M Mio, M Shimazawa and N Nakaya
      Molecular Pharmacology March 1993, 43 (3) 365-371;

  2. Nelson, D L

    1. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
      D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
      Molecular Pharmacology March 1993, 43 (3) 419-426;

  3. Neubig, R R

    1. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
      D Graeser and R R Neubig
      Molecular Pharmacology March 1993, 43 (3) 434-443;

  4. Nissen, J S

    1. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
      D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
      Molecular Pharmacology March 1993, 43 (3) 419-426;

  5. Nomura, Y

    1. Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
      T Kaneda, Y Kitamura and Y Nomura
      Molecular Pharmacology March 1993, 43 (3) 356-364;

P

  1. Pfunder, H

    1. N-hydroxylation of benzamidine to benzamidoxime by a reconstituted cytochrome P-450 oxidase system from rabbit liver: involvement of cytochrome P-450 IIC3.
      B Clement, F Jung and H Pfunder
      Molecular Pharmacology March 1993, 43 (3) 335-342;

  2. Plassat, J L

    1. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
      H Matthes, U Boschert, N Amlaiky, R Grailhe, J L Plassat, F Muscatelli, M G Mattei and R Hen
      Molecular Pharmacology March 1993, 43 (3) 313-319;

Q

  1. Quast, U

    1. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
      U Quast, K M Bray, H Andres, P W Manley, Y Baumlin and J Dosogne
      Molecular Pharmacology March 1993, 43 (3) 474-481;

R

  1. Radke, H K

    1. Modulation of gating of cloned rat and human K+ channels by micromolar Zn2+.
      N L Harrison, H K Radke, M M Tamkun and D M Lovinger
      Molecular Pharmacology March 1993, 43 (3) 482-486;

  2. Rahman, A

    1. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
      C Rohlff, B Safa, A Rahman, Y S Cho-Chung, R W Klecker and R I Glazer
      Molecular Pharmacology March 1993, 43 (3) 372-379;

  3. Rohlff, C

    1. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
      C Rohlff, B Safa, A Rahman, Y S Cho-Chung, R W Klecker and R I Glazer
      Molecular Pharmacology March 1993, 43 (3) 372-379;

  4. Rosenberg, J M

    1. Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex.
      J M Rosenberg and P H Sato
      Molecular Pharmacology March 1993, 43 (3) 491-497;

S

  1. Safa, B

    1. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
      C Rohlff, B Safa, A Rahman, Y S Cho-Chung, R W Klecker and R I Glazer
      Molecular Pharmacology March 1993, 43 (3) 372-379;

  2. Sato, P H

    1. Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex.
      J M Rosenberg and P H Sato
      Molecular Pharmacology March 1993, 43 (3) 491-497;

  3. Sausen, P J

    1. Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes.
      P J Sausen, R J Duescher and A A Elfarra
      Molecular Pharmacology March 1993, 43 (3) 388-396;

  4. Schenck, K W

    1. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
      D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
      Molecular Pharmacology March 1993, 43 (3) 419-426;

  5. Schuetz, E G

    1. Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel.
      T A Kocarek, E G Schuetz and P S Guzelian
      Molecular Pharmacology March 1993, 43 (3) 328-334;

  6. Shen, Y

    1. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
      F J Monsma, Y Shen, R P Ward, M W Hamblin and D R Sibley
      Molecular Pharmacology March 1993, 43 (3) 320-327;

  7. Shimazawa, M

    1. Histamine-induced production of interleukin-1 alpha from murine bone marrow stromal cells and its inhibition by H2 blockers.
      K Tasaka, M Mio, M Shimazawa and N Nakaya
      Molecular Pharmacology March 1993, 43 (3) 365-371;

  8. Sibley, D R

    1. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
      F J Monsma, Y Shen, R P Ward, M W Hamblin and D R Sibley
      Molecular Pharmacology March 1993, 43 (3) 320-327;

  9. Stickle, D

    1. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
      D Stickle and R Barber
      Molecular Pharmacology March 1993, 43 (3) 397-411;

T

  1. Tamkun, M M

    1. Modulation of gating of cloned rat and human K+ channels by micromolar Zn2+.
      N L Harrison, H K Radke, M M Tamkun and D M Lovinger
      Molecular Pharmacology March 1993, 43 (3) 482-486;

  2. Tasaka, K

    1. Histamine-induced production of interleukin-1 alpha from murine bone marrow stromal cells and its inhibition by H2 blockers.
      K Tasaka, M Mio, M Shimazawa and N Nakaya
      Molecular Pharmacology March 1993, 43 (3) 365-371;

  3. Thomas, R F

    1. Lack of beta 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human.
      R F Thomas and S B Liggett
      Molecular Pharmacology March 1993, 43 (3) 343-348;

W

  1. Wainscott, D B

    1. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
      D B Wainscott, M L Cohen, K W Schenck, J E Audia, J S Nissen, M Baez, J D Kursar, V L Lucaites and D L Nelson
      Molecular Pharmacology March 1993, 43 (3) 419-426;

  2. Ward, R P

    1. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
      F J Monsma, Y Shen, R P Ward, M W Hamblin and D R Sibley
      Molecular Pharmacology March 1993, 43 (3) 320-327;

  3. Weinshank, R L

    1. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
      N Adham, B Ellerbrock, P Hartig, R L Weinshank and T Branchek
      Molecular Pharmacology March 1993, 43 (3) 427-433;
Back to top

In this issue

Advertisement